Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?
Lancet Oncol
.
2021 Aug;22(8):1067-1068.
doi: 10.1016/S1470-2045(21)00203-5.
Authors
David Palma
,
Alison Tree
,
Matthias Guckenberger
PMID:
34339642
DOI:
10.1016/S1470-2045(21)00203-5
No abstract available
MeSH terms
Humans
Neoplasm Metastasis / therapy*
Radiosurgery*
Grants and funding
28284/CRUK_/Cancer Research UK/United Kingdom